103131-69-7
103131-69-7 结构式
基本信息
运动升压素
IARRHPYFL
KINETENSIN
Human kinetensin
KINETENSIN (HUMAN)
Kinetensin, ≥97% (HPLC)
253: PN: WO0069900 SEQID
NEUROTENSIN-RELATED PEPTIDE
ILE-ALA-ARG-ARG-HIS-PRO-TYR-PHE-LEU
WO0239997 SEQID: 1 unclaimed sequence
物理化学性质
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/04/30 | HY-P1255 | 升压素 Kinetensin | 103131-69-7 | 1mg | 918元 |
| 2024/04/30 | HY-P1255 | 升压素 Kinetensin | 103131-69-7 | 5mg | 1830元 |
| 2024/04/30 | HY-P1255 | 升压素 Kinetensin | 103131-69-7 | 10mg | 2940元 |
常见问题列表
Neurotensin Receptor
The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED 50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.
Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.